Lipella Pharmaceuticals Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Lipella Pharmaceuticals Inc. (LIPO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $1.36 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2025-03-28
- Lipella Pharmaceuticals Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.36M, a 135.51% increase from fiscal 2023.
- Lipella Pharmaceuticals Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $578.36K.
- Lipella Pharmaceuticals Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Lipella Pharmaceuticals Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $551.61K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2024-12-31 | $1.36M 10-K · filed 2025-03-28 |
| 2023-12-31 | $578.36K 10-K · filed 2024-02-27 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2021-12-31 | $551.61K 10-K · filed 2023-03-31 |